Conference abstract · 24 Aug 2015
Conference abstractPublished 17 Oct 2016
Robustness Quantification and Worst-case Robust Optimization in Intensity-Modulated Proton Therapy
Mayo Clinic College of Medicine, Phoenix, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Lung cancer is the leading cause of cancer death and radiation is the standard therapy for patients with unresectable disease. Intensity-modulated proton therapy (IMPT), the next evolutionary step in radiotherapy, has the extraordinary capability to precisely deposit maximum cell killing energy in tumors and minimum exposure to surrounding normal tissues; therefore, IMPT will improve the therapeutic ratio, resulting in fewer adverse effects. However, use of IMPT for lung cancer is hindered by a serious limitation: it is highly sensitive to uncertainties caused by patient setup and range uncertainties, respiratory motion, anatomic changes due to tumor shrinkage and patient weight change. These uncertainties can cause undertreatment of tumors or over-exposure of surrounding normal tissue, resulting in unfavorable clinical consequences. Therefore, it is essential to implement robustness quantification (quantifying the sensitivity of IMPT plans to uncertainties) and robust optimization (delivering precise and predictable IMPT plans to ensure the highest clinical benefit). The root mean square dose volume histograms (RVH) can be used to measure the sensitivity of the dose to uncertainties and the areas under the RVH curve (AUCs) can be used to evaluate plan robustness. Robustly optimized plans have better target coverage, improved dose homogeneity, and lower or equivalent dose to organs at risk (OARs). Additionally, robust optimization provides significantly more robust dose distributions to targets and organs than conventional optimization. Planning directly based on CTV provides better or equivalent OAR sparing. Also 4D robust optimization mitigates the influence of interplay effect than 3D robust optimization in lung cancer.
Subjects
Pulmonology & RespiratoryAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 24 Aug 2015
Comparison of simultaneous integrated boost intensity-modulated radiation therapy and conventional accelerated hyper-fractionated radiotherapy for limited disease small-cell lung cancer
Research article · 21 Oct 2017
Intensity-modulated radiation therapy in nasopharyngeal carcinoma: virtual touch tissue quantification of submandibular gland
Article · 28 Nov 2025
Dysphagia-Optimized Intensity-Modulated Radiotherapy versus Standard Intensity-Modulated Radiotherapy in Head and Neck Cancer Patients
Conference abstract · 24 Aug 2022
The exploration of optimizing intensity-modulated radiotherapy clinical target volume in lower neck to protect the thyroid gland in nasopharyngeal carcinoma
More from this journal
The newest in Pulmonary & Respiratory Medicine.
Article · 9 Feb 2026
Magnitude and Associated Factors of Respiratory Distress Syndrome among Preterm Neonate Admitted to Addis Ababa Public Hospital, Ethiopia 2023/24
Commentary · 29 Dec 2025
Evolving IPF: Personalized Therapies, Future Directions
Brief report · 29 Dec 2025
PH/PAH: Advancements, Guidelines, Future Directions
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPulmonary & Respiratory Medicine
- SubjectPulmonology & Respiratory
- BylineArticles whose byline prints “Wei Liu”

